We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£115.72
This is the most expensive it has ever been. Walk away.
£116 today · previous high £116 · all-time low £112
Springer Safety of Biologics Therapy: Monoclonal Antibodies & Proteins
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 90 days · 90 data points
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 90 days • 2 price levels
Price Analysis
Most common price: £112 (81 days, 90.0%)
Price range: £112 - £116
Price levels: 2 different prices over 90 days
Description
Key Features
Covers 13 comprehensive chapters addressing monoclonal antibodies, cytokines, fusion proteins, hormones, enzymes, coagulation proteins, vaccines and botulinum toxins with safety-focused analysis.
Examines mechanisms of action and therapeutic indications for each biologic therapy class to support clinical decision-making.
Provides detailed examination of adverse effects and immunogenicity concerns across diverse biologic agents.
Published by Springer, an established academic publisher specialising in medical and healthcare professional resources.
Designed for internal medicine practitioners and healthcare professionals managing patients receiving biologic therapies.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 3319304704
- Domain
- Amazon UK
- Release Date
- 18 May 2016
- Listed Since
- 23 January 2016
Barcode
No barcode data available
Similar Products You Might Like
Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins
Springer
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
CRC Press
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
CRC Press
Biopharmaceuticals: Biochemistry and Biotechnology
Wiley
Price unavailable
Biologics in General Medicine
Springer
Fundamentals of Medical Biotechnology (Recent Trends in Biotechnology)
Biopharmaceuticals: Challenges and Opportunities
CRC Press
Novel Frontiers in Biomedical Compound Production - Springer
Springer
Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals
Wiley
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
Elsevier
Biologics and Biosimilars: Drug Discovery and Clinical Applications
CRC Press
Biotechnology in India II: 85 (Advances in Biochemical Engineering/Biotechnology)
Springer
Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins
Wiley
Emerging Protein Biotherapeutics
CRC Press
The Biotech Business Handbook: How to Organize and Operate a Biotechnology Business, Including the Most Promising Applications for the 1990s
Humana
In vitro Environmental Toxicology - Concepts, Application and Assessment: 157 (Advances in Biochemical Engineering/Biotechnology, 157)
Springer
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics
Elsevier
Novel Therapeutics from Modern Biotechnology: From Laboratory to Human Testing: 137 (Handbook of Experimental Pharmacology, 137)
Springer
Developability of Biotherapeutics: Computational Approaches
CRC Press
Biotechnology in India I: 84 (Advances in Biochemical Engineering/Biotechnology, 84)
Springer
Biotech Industry: Global, Economic & Financing Overview
Wiley
Biotechnology in India I: 84 (Advances in Biochemical Engineering/Biotechnology)
Springer
Comprehensive Biotechnology, 2nd edition
Pergamon
Biotechnology Annual Review: 9: Volume 9
Elsevier